Heart surgery blood filter shows kidney protection promise in new analysis
NCT ID NCT06781294
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study re-analyzes data from a previous trial of 343 heart surgery patients who received a blood purification device (oXiris) connected to the heart-lung machine. The original trial found a 12% reduction in acute kidney injury within 7 days. Now researchers will examine how the filter affects antibiotics, heparin, and other drugs, and whether certain patient groups benefit more. The goal is to better understand the device's safety and effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Extracorporeal cytokine hemadsorption device (oXiris)
What this could lead to
If successful, this analysis could clarify how best to use blood purification during heart surgery to protect kidneys and guide safe antibiotic dosing.
What could go wrong
This is a post-hoc analysis of an already completed trial, not a new experiment. Findings may be less reliable and need confirmation in future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universitat de Barcelona
L'Hospitalet de Llobregat, Barcelona, 08907, Spain